Literature DB >> 26290112

Myositis Mimics.

E Harlan Michelle1, Andrew L Mammen.   

Abstract

Patients with autoimmune myositis typically present with muscle weakness, elevated serum levels of muscle enzymes, and abnormal muscle biopsies. However, patients with other acquired myopathies or genetic muscle diseases may have remarkably similar presentations. Making the correct diagnosis of another muscle disease can prevent these patients from being exposed to the risks of immunosuppressive medications, which benefit those with myositis, but not those with other types of muscle disease. Here, we review some of the most common acquired and inherited muscle diseases that can mimic autoimmune myositis, including inclusion body myositis, limb girdle muscular dystrophies, metabolic myopathies, mitochondrial myopathies, and endocrine myopathies. We emphasize aspects of the medical history, physical exam, laboratory evaluation, and muscle biopsy analysis that can help clinicians distinguish myositis mimics from true autoimmune myositis.

Entities:  

Mesh:

Year:  2015        PMID: 26290112     DOI: 10.1007/s11926-015-0541-0

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  61 in total

1.  Clinical features of Japanese patients with inclusion body myositis.

Authors:  Hiroko Hori; Satoshi Yamashita; Nozomu Tawara; Tomoo Hirahara; Kensuke Kawakami; Tomo Nishikami; Yasushi Maeda; Yukio Ando
Journal:  J Neurol Sci       Date:  2014-08-13       Impact factor: 3.181

2.  Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features.

Authors:  Stefen Brady; Waney Squier; David Hilton-Jones
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-07-16       Impact factor: 10.154

3.  Peripheral and central nervous system alterations in hypothyroidism: electrophysiological findings.

Authors:  E M Khedr; L F El Toony; M N Tarkhan; G Abdella
Journal:  Neuropsychobiology       Date:  2000-01       Impact factor: 2.328

Review 4.  Facioscapulohumeral muscular dystrophy.

Authors:  Sabrina Sacconi; Leonardo Salviati; Claude Desnuelle
Journal:  Biochim Biophys Acta       Date:  2014-05-29

Review 5.  The natural course of non-classic Pompe's disease; a review of 225 published cases.

Authors:  Léon P F Winkel; Marloes L C Hagemans; Pieter A van Doorn; M Christa B Loonen; Wim J C Hop; Arnold J J Reuser; Ans T van der Ploeg
Journal:  J Neurol       Date:  2005-08       Impact factor: 4.849

6.  A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities.

Authors:  Fieke M Cox; Maarten J Titulaer; Jacob K Sont; Axel R Wintzen; Jan J G M Verschuuren; Umesh A Badrising
Journal:  Brain       Date:  2011-09-09       Impact factor: 13.501

7.  Long-term observational study of sporadic inclusion body myositis.

Authors:  Olivier Benveniste; Marguerite Guiguet; Jane Freebody; Odile Dubourg; Waney Squier; Thierry Maisonobe; Tanya Stojkovic; Maria Isabel Leite; Yves Allenbach; Serge Herson; Stefen Brady; Bruno Eymard; David Hilton-Jones
Journal:  Brain       Date:  2011-10-12       Impact factor: 13.501

Review 8.  Pompe disease: literature review and case series.

Authors:  Majed Dasouki; Omar Jawdat; Osama Almadhoun; Mamatha Pasnoor; April L McVey; Ahmad Abuzinadah; Laura Herbelin; Richard J Barohn; Mazen M Dimachkie
Journal:  Neurol Clin       Date:  2014-08       Impact factor: 3.806

9.  Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM.

Authors:  Nizar Chahin; Andrew G Engel
Journal:  Neurology       Date:  2007-09-19       Impact factor: 9.910

10.  A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis.

Authors:  Stefen Brady; Waney Squier; Caroline Sewry; Michael Hanna; David Hilton-Jones; Janice L Holton
Journal:  BMJ Open       Date:  2014-04-28       Impact factor: 2.692

View more
  4 in total

Review 1.  [Inflammatory myopathies].

Authors:  Britta Maurer
Journal:  Z Rheumatol       Date:  2017-02       Impact factor: 1.372

Review 2.  [Dermatomyositis and juvenile dermatomyositis].

Authors:  Frank Dressler; Britta Maurer
Journal:  Z Rheumatol       Date:  2022-04-29       Impact factor: 1.372

Review 3.  Idiopathic inflammatory myopathies.

Authors:  Ingrid E Lundberg; Manabu Fujimoto; Jiri Vencovsky; Rohit Aggarwal; Marie Holmqvist; Lisa Christopher-Stine; Andrew L Mammen; Frederick W Miller
Journal:  Nat Rev Dis Primers       Date:  2021-12-02       Impact factor: 52.329

Review 4.  Dysferlinopathy misdiagnosed with juvenile polymyositis in the pre-symptomatic stage of hyperCKemia: a case report and literature review.

Authors:  Cecilia Contreras-Cubas; Francisco Barajas-Olmos; Maria Inés Frayre-Martínez; Georgina Siordia-Reyes; Claudia C Guízar-Sánchez; Humberto García-Ortiz; Lorena Orozco; Vicente Baca
Journal:  BMC Med Genomics       Date:  2022-06-20       Impact factor: 3.622

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.